Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zeyana Al-Hadhrami"'
Publikováno v:
Canadian Journal of Diabetes. 46:207-212
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of oral hypoglycemic agents commonly prescribed in type 2 diabetes (T2D). They have been shown to slow the progression of diabetic nephropathy and improve cardiovascular outcomes in
Publikováno v:
Journal of the Endocrine Society
Introduction: SGLT2 inhibitors are oral hypoglycemic medications used in type 2 diabetes mellitus (T2DM). They act by blocking glucose and sodium reabsorption in the proximal renal tubules. In patients with T2DM and cardiovascular disease, SGLT2 inhi